Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
29.07. | S&P revises Elekta AB outlook to negative amid elevated leverage | 27 | Investing.com | ||
23.07. | Elekta wins expanded FDA nod for Gamma Knife radiosurgery system | 4 | MassDevice | ||
23.07. | Elekta's Gamma Knife Gains FDA Clearance For Drug-Resistant Temporal Lobe Epilepsy | 1 | RTTNews | ||
23.07. | Elekta AB: Elekta receives U.S. FDA 510(k) clearance for its Gamma Knife radiosurgery system to treat patients with refractory, drug-resistant mesial temporal lobe epilepsy | 111 | GlobeNewswire (Europe) | New indication expands treatment options for neurosurgeons managing complex epilepsy cases
ATLANTA - Elekta (EKTA-B.ST) today announced that it has received U.S. Food and Drug Administration (FDA) 510(k)... ► Artikel lesen | |
11.06. | Citi bekräftigt Verkaufsempfehlung für Elekta-Aktie | 20 | Investing.com Deutsch | ||
11.06. | CITI REITERATES SELL RATING ON ELEKTA STOCK AMID PRICING SHIFT | 7 | Investing.com | ||
10.06. | Elekta shares down after SEK 4.9 bln order cancellation; new CEO appointed | 16 | Investing.com | ||
ELEKTA AB ADR Aktie jetzt für 0€ handeln | |||||
09.06. | Elekta announces a new CEO | 10 | MassDevice | ||
09.06. | Elekta AB: Elekta appoints Jakob Just-Bomholt as new President and CEO | 206 | GlobeNewswire (Europe) | STOCKHOLM - Elekta (EKTA-B.ST) announced today the appointment by the Board of Directors of Jakob Just-Bomholt as its new President and Chief Executive Officer, effective September 1, 2025.
Jakob, a... ► Artikel lesen | |
28.05. | Elekta AB GAAP EPS of -SEK 1.01, revenue of SEK 5.16B; initiates Q1 outlook | 18 | Seeking Alpha | ||
28.05. | Elekta AB: Year-end report May-April 2024/25 | 249 | GlobeNewswire (Europe) | Fourth quarterIn constant exchange rates, net sales increased by 6 percent mainly driven by Europe and APAC. Reported sales increased by 3 percent amounting to SEK 5,156 M (5,023).Book-to-bill ratio... ► Artikel lesen | |
03.05. | Elekta AB: Clinical trial shows more precise radiotherapy using Elekta Unity MR-Linac preserves sexual function in men with prostate cancer | 182 | GlobeNewswire (Europe) | ERECT trial used MR-guidance to spare nerves and blood vessels essential for achieving and maintaining an erection
VIENNA - Elekta (EKTA-B.ST) today announced that use of its 1.5T Elekta Unity MR-Linac... ► Artikel lesen | |
07.03. | Dividendenbekanntmachungen (07.03.2025) | 18.799 | wallstreetONLINE (Dividenden) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ACUSHNET HOLDINGS CORP US0050981085 0,235 USD 0,2177 EUR AEW UK REIT PLC GB00BWD24154 0,02 GBP EUR AMERISAFE INC US03071H1005 0... ► Artikel lesen | |
26.02. | Elekta says its CEO is stepping down | 15 | MassDevice | ||
26.02. | Elekta AB: Gustaf Salford to leave position as President and CEO of Elekta as of March 6 | 414 | GlobeNewswire (Europe) | STOCKHOLM - Elekta (EKTA-B.ST) announced today that Gustaf Salford, President and CEO, and the Board of Directors, have decided that Gustaf will leave Elekta as of March 6. Jonas Bolander, Executive... ► Artikel lesen | |
21.02. | Elekta shares tumble as company lowers full-year outlook | 9 | Investing.com | ||
21.02. | Elekta AB reports Q3 results | 6 | Seeking Alpha | ||
21.02. | Elekta AB: Q3 Report, November-January 2024/25 | 301 | GlobeNewswire (Europe) | Third quarterIn constant exchange rates, net sales increased by 2 percent mainly driven by Europe and APAC. Reported sales increased by 3 percent amounting to SEK 4,695 M (4,537).Net sales were negatively... ► Artikel lesen | |
27.11.24 | Elekta AB: Q2 Report, August-October 2024/25 | 442 | GlobeNewswire (Europe) | Second quarterIn constant exchange rates, net sales decreased by 4 percent mainly due to Europe and Latin America. Reported sales decreased by 8 percent amounting to SEK 4,341 M (4,732).Elekta Evo has... ► Artikel lesen | |
09.09.24 | Dividendenbekanntmachungen (09.09.2024) | 6.737 | wallstreetONLINE (Dividenden) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ADMIE IPTO HOLDING SA GRS518003009 - 0,0582 EUR AFRICA OIL CORP CA00829Q1019 0,025 USD 0,0225 EUR ALEXANDERWERK AG DE000A37FTW0 - 1... ► Artikel lesen |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
FAMICORD | 5,100 | +2,41 % | Original-Research: FamiCord AG (von Montega AG): Kaufen | Original-Research: FamiCord AG - von Montega AG 06.06.2025 / 17:08 CET/CEST Veröffentlichung einer Research, übermittelt durch EQS News - ein Service der EQS Group. Für den Inhalt der Mitteilung... ► Artikel lesen | |
SPINEWAY | 0,130 | +2,36 % | Spineway: H1 2025 results - Continued improvement in results and financial position | Press release Ecully, July 30, 2025 - 7 p.m. SPINEWAY H1 2025 results Continued improvement in results and financial positionFull-year 2025 growth target confirmed In thousands of... ► Artikel lesen | |
PETMED EXPRESS | 2,649 | +0,34 % | PetMed Express stock tumbles after CEO and CFO resign | ||
QUIDELORTHO | 22,400 | +0,90 % | QuidelOrtho launches certified analyzer program for rural healthcare | ||
ELEKTA | 4,226 | +1,39 % | Elekta AB: Elekta receives U.S. FDA 510(k) clearance for its Gamma Knife radiosurgery system to treat patients with refractory, drug-resistant mesial temporal lobe epilepsy | New indication expands treatment options for neurosurgeons managing complex epilepsy cases
ATLANTA - Elekta (EKTA-B.ST) today announced that it has received U.S. Food and Drug Administration (FDA) 510(k)... ► Artikel lesen | |
STAAR SURGICAL | 24,250 | +1,17 % | Pre-market Movers: Arteris, STAAR Surgical, Ichor Holdings, Inspire Medical Systems, Castle Biosciences | CAMBRIDGE (MASSACHUSETTS) (dpa-AFX) - The following are some of the stocks making big moves in Tuesday's pre-market trading (as of 08.15 A.M. ET).In the Green Arteris, Inc. (AIP) is up over... ► Artikel lesen | |
TELEFLEX | 104,00 | +0,97 % | Dividendenbekanntmachungen (15.08.2025) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) A10 NETWORKS INC US0021211018 0,06 USD 0,0514 EUR AGCO CORPORATION US0010841023 0,29 USD 0,2489 EUR ALBEMARLE CORPORATION PREF... ► Artikel lesen | |
NOVACYT | 0,479 | -1,64 % | Novacyt S.A. - Liquidity Agreement Monthly Update & TVR | ||
M3 INC | 13,700 | +0,74 % | Deutliches Plus erfreut Inhaber der M3-Aktie (12,50 €) | Grund zur Freude haben Aktionäre von M3 : Das Papier steigt deutlich. Zu den stärksten Werten des Tages gehört heute der Anteilsschein von M3 mit einem Wertanstieg von 11,61 Prozent. Für das Papier... ► Artikel lesen | |
INSPIRE MEDICAL SYSTEMS | 75,70 | -0,05 % | 13 Analysts Have This To Say About Inspire Medical Systems | ||
AMBEA | 10,390 | -1,61 % | Ambea AB: Ambea's interim report January - March 2025 | Entry into Finnish market enables increased Nordic growth
CEO comments:
After the end of the quarter, we completed the acquisition of Validia in Finland, making us the only care provider with a strong... ► Artikel lesen | |
SHIP HEALTHCARE | 12,400 | 0,00 % | Dividendenbekanntmachungen (28.03.2025) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ABERDEEN GROUP PLC ADR US00108N1000 0,3716 USD 0,3442 EUR ACOM CO LTD JP3108600002 7 JPY 0,0429 EUR ADVANEX INC JP3213400009 20... ► Artikel lesen | |
BUMRUNGRAD HOSPITAL | 4,660 | -0,43 % | Dividendenbekanntmachungen (19.03.2025) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ALL FOR ONE GROUP SE DE0005110001 - 1,6 EUR AP MOELLER-MAERSK A/S A DK0010244425 1120 DKK 150,155 EUR AP MOELLER-MAERSK A/S B DK0010244508 1120... ► Artikel lesen | |
MERCATOR MEDICAL | 10,440 | -4,74 % | Mercator Medical wants to buy back up to 124,000 of its own shares | ||
FRESENIUS | 46,610 | +1,30 % | Fresenius: Starkes Kaufsignal! | Der Trading-Tipp des Tages ist diesmal Fresenius. Die Aktie hat in dieser Woche ein neues Kaufsignal generiert. Zuletzt gab es fundamental bereits gute Nachrichten. Die Quartalszahlen waren stark. Fresenius... ► Artikel lesen |